Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
54
PRI Quote, Financials, Valuation and Earnings
Last price:
$260.32
Seasonality move
:
3.6%
Day range:
$259.51 - $265.36
52-week range:
$211.53 - $307.91
Dividend yield:
1.36%
P/E ratio:
19.26x
P/S ratio:
2.91x
P/B ratio:
3.90x
Volume:
135.6K
Avg. volume:
207.6K
1-year change:
23.35%
Market cap:
$8.8B
Revenue:
$3.1B
EPS (TTM):
$13.75
Analysts' Opinion
-
Consensus RatingPrimerica has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $298.71, Primerica has an estimated upside of 12.8% from its current price of $264.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $262.00 representing 100% downside risk from its current price of $264.81.
Fair Value
-
According to the consensus of 9 analysts, Primerica has 12.8% upside to fair value with a price target of $298.71 per share.
PRI vs. S&P 500
-
Over the past 5 trading days, Primerica has overperformed the S&P 500 by 2.52% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Primerica does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Primerica has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Primerica reported revenues of $788.1M.
Earnings Growth
-
Primerica has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Primerica reported earnings per share of $4.96.
Enterprise value:
9B
EV / Invested capital:
--
Price / LTM sales:
2.91x
EV / EBIT:
13.16x
EV / Revenue:
2.90x
PEG ratio (5yr expected):
0.45x
EV / Free cash flow:
10.83x
Price / Operating cash flow:
10.87x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.18%
Net Income Margin (TTM):
15.14%
Return On Equity:
22.24%
Return On Invested Capital:
11.59%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.7B | $2.8B | $3.1B | $706.2M | $788.1M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $12.19 | $15.96 | $13.75 | $4.30 | $4.96 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.6B | $7.9B | $6.7B | $6.6B | $4.7B | |
| Total Assets | $14.9B | $16.1B | $14.6B | $15B | $14.6B | |
| Current Liabilities | $540.8M | $615.7M | $575.1M | $536.5M | $546.3M | |
| Total Liabilities | $13.1B | $14B | $12.6B | $13B | $12.3B | |
| Total Equity | $1.8B | $2.1B | $2B | $2.1B | $2.3B | |
| Total Debt | $1.7B | $2B | $2B | $2B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $757.7M | $692.5M | $862.1M | $241.1M | $270.6M | |
| Cash From Investing | -$200M | -$90.1M | -$232.3M | -$2.2M | -$50.7M | |
| Cash From Financing | -$457.9M | -$479.6M | -$551.1M | -$95.8M | -$79.4M | |
| Free Cash Flow | $731.9M | $658.6M | $832.9M | $220.8M | $268.1M | |
PRI
Sector
Market Cap
$8.8B
$603.7M
Price % of 52-Week High
86%
84.45%
Dividend Yield
1.36%
2.05%
Shareholder Yield
6.2%
3.98%
1-Year Price Total Return
23.35%
9.07%
Beta (5-Year)
1.034
0.555
Dividend yield:
1.36%
Annualized payout:
$3.30
Payout ratio:
23.98%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$258.46
200-day SMA
Sell
Level
$272.94
Bollinger Bands (100)
Sell
Level
265.73 - 292.97
Chaikin Money Flow
Buy
Level
34.5M
20-day SMA
Buy
Level
$259.71
Relative Strength Index (RSI14)
Sell
Level
49.82
ADX Line
Sell
Level
25.53
Williams %R
Sell
Level
-2.0839
50-day SMA
Sell
Level
$274.30
MACD (12, 26)
Sell
Level
-4.29
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
33.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4279)
Sell
CA Score
(Annual)
Level (-1.7152)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.1554)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the US.
Stock Forecast FAQ
In the current month, PRI has received 2 Buy ratings 7 Hold ratings, and 0 Sell ratings. The PRI average analyst price target in the past 3 months is $298.71.
-
Where Will Primerica Stock Be In 1 Year?
According to analysts, the consensus estimate is that Primerica share price will rise to $298.71 per share over the next 12 months.
-
What Do Analysts Say About Primerica?
Analysts are divided on their view about Primerica share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Primerica is a Sell and believe this share price will drop from its current level to $262.00.
-
What Is Primerica's Price Target?
The price target for Primerica over the next 1-year time period is forecast to be $298.71 according to 9 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is PRI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Primerica is a Hold. 7 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of PRI?
You can purchase shares of Primerica via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Primerica shares.
-
What Is The Primerica Share Price Today?
Primerica was last trading at $260.32 per share. This represents the most recent stock quote for Primerica. Yesterday, Primerica closed at $264.81 per share.
-
How To Buy Primerica Stock Online?
In order to purchase Primerica stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 6.05% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2.03% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.31% over the past day.
